The food allergy treatment market size has grown rapidly in recent years. It will grow from $6.08 billion in 2023 to $6.82 billion in 2024 at a compound annual growth rate (CAGR) of 12.2%. The growth during the historic period can be credited to the rise in food allergies, increased regulatory approvals, advancements in emergency treatments, and higher investments in modern technologies.
The food allergy treatment market size is expected to see rapid growth in the next few years. It will grow to $10.84 billion in 2028 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to the expanding elderly population, growing diagnoses of food allergies, increased healthcare expenditure, rising incidences of asthma, and higher prevalence of food allergies. Key trends in this period include significant innovation and technological advancements, improvements in medical technology and diagnostics, increased use of mobile apps and telemedicine services, growth in research and development activities, and a surge in drug approvals and launches.
The rise in food adulteration is expected to drive growth in the food allergy treatment market in the future. Food adulteration involves intentionally altering food products by adding inferior, harmful, or unauthorized substances or by removing valuable ingredients to increase quantity or improve appearance, often at the expense of quality and safety. This practice is increasing due to economic incentives, complex supply chains, inadequate regulation, technological advancements, demand for convenience, globalization, environmental factors, consumer awareness, profit motives, and weak enforcement of regulations. The growing prevalence of food adulteration is primarily driven by the demand for more affordable products, prompting producers to reduce costs and maximize profits through unethical means. This can elevate the risk of allergic reactions by introducing allergens into food products or compromising their safety and integrity. For example, Europol reported in November 2022 that nearly 27,000 tons of counterfeit food and 15 million liters of alcoholic beverages were seized across 26 countries between December 2021 and May 2022 as part of Operation OPSON XI. Consequently, the increasing incidence of food adulteration is fostering expansion in the food allergy treatment market.
Leading companies in the food allergy treatment sector are advancing innovative therapies, such as monoclonal antibodies, to target the underlying mechanisms of food allergies and deliver more effective treatments. Monoclonal antibodies offer a promising strategy for managing food allergies by pinpointing specific components of the immune system involved in allergic responses, thereby enhancing treatment efficacy for patients. For instance, in February 2024, Novartis AG obtained FDA approval for Xolair (omalizumab) to mitigate IgE-mediated food allergies. This humanized monoclonal antibody is administered subcutaneously and functions by blocking IgE antibody binding, thereby reducing the release of allergen-triggering chemicals. FDA clearance was supported by positive findings from the Phase III OUtMATCH study, demonstrating that a significantly higher proportion of food allergy patients, including children as young as 1 year, treated with Xolair could tolerate small amounts of peanuts, milk, eggs, and cashews without adverse reactions compared to those receiving a placebo.
In September 2023, Stallergenes Greer acquired Nestlé's peanut allergy treatment division for an undisclosed sum, enabling Nestlé to concentrate on core competencies and growth sectors while expanding Stallergenes Greer's allergy treatment offerings. Nestlé, headquartered in Switzerland, specializes in food allergy prevention and treatment.
Major companies operating in the food allergy treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca PLC, Novartis AG, Amgen Inc., Regeneron Pharmaceuticals Inc., Parexel International (MA) Corporation, Nestle Health Science, ALK-Abelló A/S, Stallergenes Greer, Kaleo Inc., HAL Allergy B.V., Vedanta Biosciences Inc., Aimmune Therapeutics, AnaptysBio Inc., Immunomic Therapeutics Inc., Alladapt Immunotherapeutics Inc., Aravax, Prota Therapeutics Pty Ltd., DBV Technologies, Adamis Pharmaceuticals Corporation.
North America was the largest region in the food allergy treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the food allergy treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the food allergy treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Treatment for food allergies involves various medical interventions aimed at preventing, managing, and treating allergic reactions triggered by specific foods. The primary objective is to decrease the frequency and severity of these reactions, improve the quality of life for affected individuals, and ensure overall patient safety.
In food allergy treatment, several types of medications play crucial roles. These include antihistamines, decongestants, corticosteroids, mast cell stabilizers, leukotriene inhibitors, nasal anti-cholinergic drugs, immuno-modulators, epinephrine, and immunotherapy. Antihistamines, for example, are medications used to relieve symptoms resulting from allergic reactions. They can be administered orally or parenterally to address various allergens such as dairy products, poultry, tree nuts, peanuts, shellfish, wheat, soy, among others. These medications are readily available from hospital pharmacies, retail pharmacies, and other distributors.
The food allergy treatment market research report is one of a series of new reports that provides food allergy treatment market statistics, including the food allergy treatment industry global market size, regional shares, competitors with food allergy treatment market share, detailed food allergy treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the food allergy treatment industry. These food allergy treatment market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The food allergy treatment market consists of revenues earned by entities by providing services such as diagnostic testing, pharmaceutical treatments, immunotherapy, nutritional supplements, emergency kits, educational programs, dietary counseling, telemedicine solutions, and research and development efforts. The market value includes the value of related goods sold by the service provider or included within the service offering. The food allergy treatment market also includes sales of medical devices, such as epinephrine auto-injectors, allergy management kits, and medical alert accessories. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The food allergy treatment market size is expected to see rapid growth in the next few years. It will grow to $10.84 billion in 2028 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to the expanding elderly population, growing diagnoses of food allergies, increased healthcare expenditure, rising incidences of asthma, and higher prevalence of food allergies. Key trends in this period include significant innovation and technological advancements, improvements in medical technology and diagnostics, increased use of mobile apps and telemedicine services, growth in research and development activities, and a surge in drug approvals and launches.
The rise in food adulteration is expected to drive growth in the food allergy treatment market in the future. Food adulteration involves intentionally altering food products by adding inferior, harmful, or unauthorized substances or by removing valuable ingredients to increase quantity or improve appearance, often at the expense of quality and safety. This practice is increasing due to economic incentives, complex supply chains, inadequate regulation, technological advancements, demand for convenience, globalization, environmental factors, consumer awareness, profit motives, and weak enforcement of regulations. The growing prevalence of food adulteration is primarily driven by the demand for more affordable products, prompting producers to reduce costs and maximize profits through unethical means. This can elevate the risk of allergic reactions by introducing allergens into food products or compromising their safety and integrity. For example, Europol reported in November 2022 that nearly 27,000 tons of counterfeit food and 15 million liters of alcoholic beverages were seized across 26 countries between December 2021 and May 2022 as part of Operation OPSON XI. Consequently, the increasing incidence of food adulteration is fostering expansion in the food allergy treatment market.
Leading companies in the food allergy treatment sector are advancing innovative therapies, such as monoclonal antibodies, to target the underlying mechanisms of food allergies and deliver more effective treatments. Monoclonal antibodies offer a promising strategy for managing food allergies by pinpointing specific components of the immune system involved in allergic responses, thereby enhancing treatment efficacy for patients. For instance, in February 2024, Novartis AG obtained FDA approval for Xolair (omalizumab) to mitigate IgE-mediated food allergies. This humanized monoclonal antibody is administered subcutaneously and functions by blocking IgE antibody binding, thereby reducing the release of allergen-triggering chemicals. FDA clearance was supported by positive findings from the Phase III OUtMATCH study, demonstrating that a significantly higher proportion of food allergy patients, including children as young as 1 year, treated with Xolair could tolerate small amounts of peanuts, milk, eggs, and cashews without adverse reactions compared to those receiving a placebo.
In September 2023, Stallergenes Greer acquired Nestlé's peanut allergy treatment division for an undisclosed sum, enabling Nestlé to concentrate on core competencies and growth sectors while expanding Stallergenes Greer's allergy treatment offerings. Nestlé, headquartered in Switzerland, specializes in food allergy prevention and treatment.
Major companies operating in the food allergy treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca PLC, Novartis AG, Amgen Inc., Regeneron Pharmaceuticals Inc., Parexel International (MA) Corporation, Nestle Health Science, ALK-Abelló A/S, Stallergenes Greer, Kaleo Inc., HAL Allergy B.V., Vedanta Biosciences Inc., Aimmune Therapeutics, AnaptysBio Inc., Immunomic Therapeutics Inc., Alladapt Immunotherapeutics Inc., Aravax, Prota Therapeutics Pty Ltd., DBV Technologies, Adamis Pharmaceuticals Corporation.
North America was the largest region in the food allergy treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the food allergy treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the food allergy treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Treatment for food allergies involves various medical interventions aimed at preventing, managing, and treating allergic reactions triggered by specific foods. The primary objective is to decrease the frequency and severity of these reactions, improve the quality of life for affected individuals, and ensure overall patient safety.
In food allergy treatment, several types of medications play crucial roles. These include antihistamines, decongestants, corticosteroids, mast cell stabilizers, leukotriene inhibitors, nasal anti-cholinergic drugs, immuno-modulators, epinephrine, and immunotherapy. Antihistamines, for example, are medications used to relieve symptoms resulting from allergic reactions. They can be administered orally or parenterally to address various allergens such as dairy products, poultry, tree nuts, peanuts, shellfish, wheat, soy, among others. These medications are readily available from hospital pharmacies, retail pharmacies, and other distributors.
The food allergy treatment market research report is one of a series of new reports that provides food allergy treatment market statistics, including the food allergy treatment industry global market size, regional shares, competitors with food allergy treatment market share, detailed food allergy treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the food allergy treatment industry. These food allergy treatment market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The food allergy treatment market consists of revenues earned by entities by providing services such as diagnostic testing, pharmaceutical treatments, immunotherapy, nutritional supplements, emergency kits, educational programs, dietary counseling, telemedicine solutions, and research and development efforts. The market value includes the value of related goods sold by the service provider or included within the service offering. The food allergy treatment market also includes sales of medical devices, such as epinephrine auto-injectors, allergy management kits, and medical alert accessories. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Food Allergy Treatment Market Characteristics3. Food Allergy Treatment Market Trends and Strategies32. Global Food Allergy Treatment Market Competitive Benchmarking33. Global Food Allergy Treatment Market Competitive Dashboard34. Key Mergers and Acquisitions in the Food Allergy Treatment Market
4. Food Allergy Treatment Market - Macro Economic Scenario
5. Global Food Allergy Treatment Market Size and Growth
6. Food Allergy Treatment Market Segmentation
7. Food Allergy Treatment Market Regional and Country Analysis
8. Asia-Pacific Food Allergy Treatment Market
9. China Food Allergy Treatment Market
10. India Food Allergy Treatment Market
11. Japan Food Allergy Treatment Market
12. Australia Food Allergy Treatment Market
13. Indonesia Food Allergy Treatment Market
14. South Korea Food Allergy Treatment Market
15. Western Europe Food Allergy Treatment Market
16. UK Food Allergy Treatment Market
17. Germany Food Allergy Treatment Market
18. France Food Allergy Treatment Market
19. Italy Food Allergy Treatment Market
20. Spain Food Allergy Treatment Market
21. Eastern Europe Food Allergy Treatment Market
22. Russia Food Allergy Treatment Market
23. North America Food Allergy Treatment Market
24. USA Food Allergy Treatment Market
25. Canada Food Allergy Treatment Market
26. South America Food Allergy Treatment Market
27. Brazil Food Allergy Treatment Market
28. Middle East Food Allergy Treatment Market
29. Africa Food Allergy Treatment Market
30. Food Allergy Treatment Market Competitive Landscape and Company Profiles
31. Food Allergy Treatment Market Other Major and Innovative Companies
35. Food Allergy Treatment Market Future Outlook and Potential Analysis
36. Appendix
Executive Summary
Food Allergy Treatment Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on food allergy treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for food allergy treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The food allergy treatment market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
- The impact of higher inflation in many countries and the resulting spike in interest rates.
- The continued but declining impact of COVID-19 on supply chains and consumption patterns.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Drug Type: Antihistamines; Decongestants; Corticosteroids; Mast Cell Stabilizers; Leukotriene Inhibitors; Nasal Anti-Cholinergic; Immuno-Modulators; Epinephrine; Immunotherapy2) By Route Of Administration: Parenteral; Oral
3) By Allergen Type: Dairy Products; Poultry Product; Tree Nuts; Peanuts; Shellfish; Wheat; Soys; Other Allergens
4) By End-Use: Hospital Pharmacies; Retail Pharmacies; Other End-Uses
Key Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Bayer AG; Sanofi S.A.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Pfizer Inc.
- F. Hoffmann-La Roche Ltd.
- Merck & Co. Inc.
- Bayer AG
- Sanofi S.A.
- AstraZeneca PLC
- Novartis AG
- Amgen Inc.
- Regeneron Pharmaceuticals Inc.
- Parexel International (MA) Corporation
- Nestle Health Science
- ALK-Abelló A/S
- Stallergenes Greer
- Kaleo Inc.
- HAL Allergy B.V.
- Vedanta Biosciences Inc.
- Aimmune Therapeutics
- AnaptysBio Inc.
- Immunomic Therapeutics Inc.
- Alladapt Immunotherapeutics Inc.
- Aravax
- Prota Therapeutics Pty Ltd.
- DBV Technologies
- Adamis Pharmaceuticals Corporation
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 175 |
Published | August 2024 |
Forecast Period | 2024 - 2028 |
Estimated Market Value ( USD | $ 6.82 Billion |
Forecasted Market Value ( USD | $ 10.84 Billion |
Compound Annual Growth Rate | 12.3% |
Regions Covered | Global |